Delivery Order SPE2DB22D7058-SPE2DB23FV4ZB

Award Date 8/2/23
Potential Completion Date 8/3/23
Potential Value $22
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $258.24 to Amerisourcebergen Drug Corp for 4561707431 memantine hydrochloride 10 mg tablets. The order is for 100 count bottles of the generic Alzheimer's drug and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 7, 2023. As a major supplier of pharmaceuticals to the Department of Defense through contracts like its Pharmaceutical Prime Vendor program, this order for...
The Defense Logistics Agency awarded a $87,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562071682 memantine hydrochloride 5 mg tablets. The order is for 100 units to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract from September 6 through September 7, 2023. The Defense Logistics Agency...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $86.08 to Amerisourcebergen Drug Corp for 4561464145 memantine HCL 10 mg tablets. The order is for 100 tablets to be delivered to Conshohocken, Pennsylvania by July 12, 2023 from the prime contractor's corporate office. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will perform under the contract from its Conshohocken location. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $1.55 million firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561597862 memantine hydrochloride 10 mg tablets (60 count). The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 26, 2023 in support of Department of Defense requirements. Amerisourcebergen will perform under this delivery order issued against their Prime Vendor Next contract vehicle, through which DLA...
The Defense Logistics Agency awarded a $1.55 million firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561599269 memantine hydrochloride 10 mg tablets, 60 count. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania to support the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were identified. The...
The Defense Logistics Agency awarded a $6,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 boxes of 10mg memantine hydrochloride tablets. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 17, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued under the Defense Logistics Agency's...
The Defense Logistics Agency awarded a $37,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 boxes of 10mg memantine hydrochloride tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for delivery between June 27-28, 2023 to support the Defense Logistics Agency's pharmaceutical procurement and distribution programs. No subcontractors or set aside designations were specified. The award draws upon...
Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $12,400 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 60 tablets of 10 mg memantine hydrochloride. The single day contract has a period of performance from August 7-8, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether...
The Defense Logistics Agency Troop Support Medical awarded a $23,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 tablets of 5 mg memantine hydrochloride. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 15-16, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this order for pharmaceutical products in support of DLA Troop...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at thirty-three thousand seven hundred dollars to supply sixty count bottles of the pharmaceutical memantine hydrochloride, a drug used to treat Alzheimer's disease. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. As a top supplier to the Department of Defense through contracts like the...
  • SPE2DB22D7058
    Indefinite Delivery Contract
  • SPE2DB22D7058-SPE2DB23FV4ZB
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $21,520 to Amerisourcebergen Drug Corporation for 4561674302 memantine hydrochloride 10 mg tablets. The order is for 100 strips of the generic Alzheimer's drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and performed within a one day period concluding on August 3, 2023. Amerisourcebergen Corporation is the identified parent company for this sole source prime contractor. The award draws from DLA's pharmaceuticals procurement programs to support the treatment needs of military personnel, veterans, and their families.

Generated 12/18/23, 2:29 AM